AngioDynamics, Inc. ANGO, yesterday, announced the receipt of the FDA’s 510(k) clearance for the NanoKnife System for ...

From a Hollywood star sharing an uplifting update to the death of a three-time boxing champion, here’s what’s happening in ...

Microwave ablation devices are revolutionizing the medical field, particularly in oncology, by providing minimally invasive, ...

The CAIRO5 trial confirmed the benefit of both two-drug chemotherapy regimens with bevacizumab instead of a three-drug ...

RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, 1 – 4. RSNA is the largest conference show in the field of radiology which opens new horizons for the company ...

Dolph Lundgren has declared he is 'cancer-free' after being told he had years left to live. Dolph Lundgren is "cancer-free" ...

Ablation has proven highly successful and often cures tachycardia, although pharmacological therapy can be used for the acute onset of the tachycardia. In certain instances of infrequent episodes ...

Patients who presented with tolerated VT and who had an LVEF >35% were offered catheter ablation as first-line therapy. ICD implantation was offered to all patients but was subject to shared decision ...

Hepatic artery infusion, or HAI, also carries a green light for bile duct cancer that is fully confined to the liver. “Interest in HAI therapy has grown in the oncology community given improved ...

Gene therapy that selectively delivers the SMN1 gene to the liver reduced alterations related to spinal muscular atrophy (SMA) in a mouse model, restoring muscle size and correcting pancreatic issues.

The safety profile of SCG101 was generally favourable, with the therapy being well tolerated. The most commonly reported treatment-related adverse events included transient elevations in liver enzymes ...

However, whether or not laparoscopic liver resection (LLR) or radiofrequency ablation (RFA) is a better treatment option remains debatable. We conducted a meta-analysis to review the published data ...